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Abstract
The relationships of critical nutrients such as plant phenolics, vitamins, minerals and lipids are
considered with respect to the incidence of a variety of cancers, and analyzed in terms of how these
nutrient deficiencies alter immune function, DNA integrity and cell proliferation. With a significant
correlation found between cancer and these nutrient deficiencies, the hypothesis is presented here
that nutrition could provide a unifying perception of cancer and recast it as a single disease. This
further suggests that a coordinated administration of specific, critical nutrients to cancer patients
could lead to the reversal of the disease. It is also proposed that the concurrent presence of a
variety of nutritional deficiencies in cancer patients requires a multilevel, systemic approach to this
disease as opposed to the single active therapeutic agent approach that is the cornerstone of
contemporary research and pharmacology.
Introduction
In the 20th century, major structural changes took place in
the countries of the developed world. Primarily agrarian
societies were transformed into industrial societies with
the accompanying migration of the majority of the popu-
lation into large urban centers. This led to major lifestyle
changes with unforeseen consequences. Diet in early 20th
century agrarian societies was primarily based on organi-
cally produced fresh food. Food production was mainly
carried out in relatively small family operations utilizing
organic farming methods. By the end of the century, the
landscape had completely transformed into large-scale
industrial farming, utilizing non-organic production
methods along with an industrial processing and distribu-
tion system for the majority of essential food items.
Dietary patterns were thoroughly transformed. Data show
that per capita energy consumption increased signifi-
cantly and within that, the fat and animal protein seg-
ments more than tripled [1,2]. Although fruit and
produce consumption also increased, most of it is not
consumed fresh [3]. Due to widespread food processing,
the energy density of our foods also increased [1]. The
now commonplace refrigeration and freeze storage
removed the need for fresh food prepared daily and
allowed the distribution of a wide variety of manufactured
food products. These changes did not necessarily lead to a
quality improvement in our nutrition. Along with these
changes, physical activities decreased which may well
have contributed to the now-epidemic proportions of
obesity in the Western world.
Environmental factors
Although cancer is primarily considered to be genetically
linked, it is now well established that diet has a significant
effect on cancer incidence [4-6]. In fact, food consump-
tion patterns could provide major insights into cancer risk
and prevention despite the fact that their significance is
not fully appreciated [7]. The changes in cancer incidence
in migrant populations moving from low cancer inci-
dence to high cancer incidence environments clearly dem-
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onstrate that environmental factors are more important
than genetics [8,9].
Among the developed countries, Japan continues to
exhibit the lowest cancer incidence in the major cancers
types, including lung, breast and colon carcinomas,
although some cancers have increased in incidence due to
the introduction of Western dietary practices [10,11].
Notably, immigrant Japanese in California and Hawaii
has a much higher incidence of breast and colon cancer
[8,9]. In Japan, the consumption of fresh, raw foods con-
tinues to remain important even though in all other
aspects (industrialization and urbanization) the Japanese
have adapted the Western model. In addition, the Japa-
nese have the same risk factors such as smoking, alcohol
consumption and sedentary life styles as Westerners. The
only notable exception in risk factors is the relative rarity
of obesity in Japan, a difference that is also attributable to
dietary customs.
Another line of evidence comes from Australia, demon-
strating the increase in colon cancer mortality among
immigrant populations originating from low-incidence
countries [12]. Similar observations were made in some
South Pacific Islander groups where the incidence of lung
cancer is extremely low despite high rates of smoking [13].
Over the past decades, population-based approaches have
identified food classes or nutrients that confer protection
from various cancers or enhanced the risk of cancer [14-
17]. In fact, there is evidence that dietary manipulations
may be protective against 10–70% of all cancers, and may
be as high as 50–70% against colon cancer [18,19].
Plant phenolics
Epidemiological studies implicated high-saturated dietary
fat and protein as a risk factor for colon cancer and estab-
lished that high fiber, high fruit and vegetable content are
protective [17,18]. The success of the dietary fiber hypoth-
esis [20,21] is particularly intriguing in light of the recog-
nition that the actual protective agent is not the fiber itself,
but the cell wall components, phenolic polysaccharides
and polyphenols [22-27]. The protective phenolic lignin
and hemicellulose components are present in widely dif-
ferent concentrations in the cell walls of various plants
and are released by bacterial enzymes in the human colon
[23]. Such compounds have been isolated, e.g. from rice
bran and green tea, and their cancer protective effects
demonstrated [24,25,27]. Processed rice bran, however,
had no such protective effect [28]. Many of these com-
pounds have antioxidant, anti-mutagenic, anti-carcino-
genic and anti-inflammatory effects that may be
responsible for their anticancer effects [29].
A readily available source for such phenolic polysaccha-
rides can be located in the nutritional and medical prac-
tices of the 19th and early 20th centuries [30,31]. Sugar
cane molasses, a widely used nutrient, was served as a
sweetener instead of purified sugar, stirred into milk and
eaten instead of jam or jelly. It was also a popular medic-
inal agent:recent analyses demonstrated it to be a rich
source of micro- and macronutrients [32]. Blackstrap
molasses, its most concentrated form, was used for the
therapy of a variety of diseases, including cancer [31].
Anecdotal evidence suggests that cancer was very rare
among sugar cane plantation workers who were regularly
consuming the raw brown sugar [33]. Blackstrap molasses
is rich in a variety of essential minerals including iron,
zinc, selenium, magnesium and potassium as well as the
majority of the vitamin B complex [33], deficiencies of
which confer a major cancer risk [34]. Molasses also con-
tains high concentrations of amino acids and linoleic acid
[35], an essential lipid that has a documented anti-tumor
effect [36,37].
Cane molasses is fed widely to domestic animals [35]. A
feeding study on the phenolic carbohydrate compounds
of cane molasses suggested that they are beneficial to both
ruminant and non-ruminant animals [38]. The feeding of
8% sugar cane bagasse to broiler chicken demonstrated
weight gain and carcass quality as well as elevated immu-
noglobulin levels [39]. Recent data on cane molasses
appear to lend support to historical accounts concerning
its effectiveness as both preventative and a possible cura-
tive agent for some cancer.
Folate, vitamin B12 and other micronutrients
In the past decade it became apparent that low normal
levels of certain vitamins may cause diseases in at-risk
populations, such as middle to elderly age groups and
pregnant women, and that such abnormalities might be
overcome by ensuring high normal plasma levels of the
respective vitamins [40-42]. Metabolic defects of folate are
associated with circulatory diseases [43,44] as well as neu-
ral and cognitive disorders [45]. Folate deficiency has
recently been associated with pathogenesis in a variety of
malignancies [46-50]. The most understood functions of
folate and vitamin B12 are in the area of synthesis of
purines and pyrimidines, as well as the maintenance of
the methylation process that is essential for regulated cell
division [51].
Several lines of evidence, both in vitro and in vivo, suggest
that folate deficiency has pro-neoplastic effects. Deoxynu-
cletide pool imbalance and uracil misincorporation into
DNA in folate deficient cell lines has been described
[52,53]. Enhanced development of colonic neoplasia was
observed in a folate-deficient rat model [54,55]. Several
human studies demonstrate that folate deficiency may
potentiate neoplastic processes and that high dietary
folate intake is protective [46-50,56]. It is well establishedJournal of Carcinogenesis 2003, 2 http://www.carcinogenesis.com/content/2/1/9
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that folate deficiency leads to nucleotide pool imbalance
(uracil misincorporation), DNA strand breaks [57,58],
hypomethylation of DNA [59-61], increased gene expres-
sion [62-64], altered chromatin conformation [63,64], as
well as altered cellular proliferation [62,67]. All these phe-
nomena have been associated with carcinogenesis and
tumorigenesis.
It has been recommended that patients undergoing
chronic methotrexate or other antifolate therapy increase
folate intake [68]. In such cases, high dose of folic acid (5
mg/day) have reduced therapy-associated toxicity with
apparent preservation of antitumor activity [69]. This sup-
ports the view that antifolates act through a direct cyto-
toxic mechanism [70].
There is a close interrelationship between folate and vita-
min B12 in the synthesis, repair and methylation of DNA.
In a human clinical trial, a three-month-long supplemen-
tation with 3.5 times the Australian Recommended Daily
Allowance (RDA) for folic acid and vitamin B12 was
found to reduce micronuclei frequency, a DNA damage
marker, in healthy young adults by 25% [71]. This study
emphasized that supplementation levels higher than the
RDA may be required in large populations to minimize
DNA damage. Our RDAs were based on information on
acute effects, because optimum amounts for long-term
health is unknown. However, these data suggest that RDA
levels may need to be reevaluated to make sure that ade-
quate levels of these nutrients are available for genomic
stability.
Supplementation with folic acid and vitamin B12 has
reduced the severity of smoking-induced bronchial meta-
plasia in humans [72,73], underscoring the importance of
these vitamins. Folate and vitamin B12 deficiencies that
lead to chromosome breaks affect a significant 10–14% of
the U.S. population [74-77]. The two deficiencies may act
synergistically. Vitamin B6, which also participates in
DNA methylation, was also found to be deficient in about
10% of the U.S. population [76].
Besides the above micronutrients, niacin, iron, selenium
and zinc deficiencies that also affect DNA integrity are
common in the United States [76,78]. All these data sug-
gest that micronutrient deficiencies, which can mimic
radiation or chemical damage to DNA, are affecting a con-
siderable proportion of the U.S. population, and the cor-
rection of these deficiencies will be a major public health
concern in the coming decades.
Iodine
Iodine is another critical micronutrient, and iodine defi-
ciency has a profound effect on human health [79,80].
Mild to moderate iodine deficiency has been associated
with an extraordinarily high occurrence of hyperthy-
roidism in at-risk populations [81]. Epidemiological stud-
ies have established that the incidence of goiter runs
parallel to that of thyroid cancer [82-84]. In a rat model,
iodine deficiency has been found to be a more efficient
tumor promoter than the carcinogen itself [85].
The relationship between thyroid function and breast
physiology was strengthened by observations that repro-
ducible breast dysplasia and neoplasia were obtained in
iodine deficiency that was reversible with iodine replace-
ment [86,87]. Breast cancer patients as a group were
found to have a lower thyroid function than women hav-
ing conditions unrelated to breast cancer [88].
It has been pointed out that in the U.S., breast cancer
tends to occur in geographical areas associated with
iodine deficiency [89]. In contrast, in Japan, where iodine
intake levels are higher, a much lower breast cancer inci-
dence is observed [90]. Fibrocystic breast disease, a known
risk factor for breast cancer, can largely be prevented by
iodine supplementation [91]. In this study, molecular
iodine was found to be more effective than iodide, the
currently favored form of iodine supplementation. In
iodine supplementation studies unrelated to cancer,
molecular iodine complexed to lipids was also found to
be more effective than iodide [92]. It was also reported
that iodolipids formed from iodine in the thyroid gland
may play a role in providing proliferative control in breast
tissue [93]. Another observation is that in old Pharmaco-
poeias, for oral iodine administration the molecular form
was prescribed [94].
While breast cancer rates in Japan have been compara-
tively low, they have been increasing recently: this has
been associated with the "Westernization" of the country's
diet [11]. A study from Spain also established a link
between regions of iodine deficiency and breast cancer
mortality rates [95]. Traditional Eastern Asian medicine
has long used iodine-rich seaweed for cancer treatment
[96]. This observation is interesting in light of the fact that
in malignant thyroid nodules, the iodine concentration
was found to be 15 times lower than in benign nodules
[97], demonstrating severe iodine deficiency in the tumor
tissue. Recent studies with animal models support the
anti-cancer effect of iodine [98,99].
Iodine deficiency has a profound negative effect on the
immune system [100]. A significant immune deficiency
has been reported among patients with gastric cancer, thy-
roid cancer and goiter [101]. Iodine was also found to
increase immunoglobulin G synthesis in vitro in human
lymphocytes [102]. Impaired capacity of immunoglobu-
lin production in active cancer patients has been observed
[103], which might be modulated by iodine supplemen-Journal of Carcinogenesis 2003, 2 http://www.carcinogenesis.com/content/2/1/9
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tation. These observations indicate that iodine has a direct
effect on the immune system and anticancer defenses.
In 1990, statistics showed that iodine deficiency affected
about one-third of the world's population, and despite
efforts to correct this problem, it persists. A recent study
from South Africa indicated a significant iodine deficiency
country-wide [84]. Another study from Switzerland
reported that despite more than 80 years of a national
iodine supplementation program, only 24% of the partic-
ipants in the healthy volunteer group reached the WHO
recommended level for dietary iodine intake, indicating a
significant iodine deficiency among the Swiss [104]. This
result was attributed to the growing consumption of man-
ufactured food products deficient in iodine. Although
similar data is not available for the United States, a com-
parable level of development and the high popularity of
manufactured foods suggest that the US situation is likely
not much different from that in Switzerland.
Lipids
It has been previously discussed that the essential lipid
linoleic acid present in cane molasses has antitumor
effects. Such lipids are also found at high concentrations
in rose oil [105], which has a history of medicinal use dat-
ing back at least 5,000 years. The traditional Indian
Ayurvedic medical practice uses oral rose oil for the treat-
ment of a variety of inflammatory conditions, as well as
emotional stress [106]. Anti-anxiety effects of rose oil have
recently been confirmed [107]. Rose oil is a potent inhib-
itor of the growth of Helicobacter pylori [108], implicated
in the etiology of gastric cancer. Therefore, rose oil may
exert a "sanitizing" effect in the gut. It has also been sug-
gested that rose oil may be valuable for human consump-
tion because of its high unsaturated lipid content [105].
The gastrointestinal link
The general processing capacity of the digestive tract plays
a critical role in both health and disease. Traditional
Indian Ayurvedic medicine states that health requires
robust digestion [109]. Under conditions of prolonged
stress, the secretion of digestive juices is diminished,
reducing the digestive capacity in the gut.
Impaired digestion has been implicated in the patho-
mechanism of cancer for nearly a century: in 1906, pan-
creatic proteolytic enzymes were demonstrated to defend
the body against cancer [110]. This finding was followed
up during the first decade of the century, with the publica-
tion of tumor regression as well as remission in terminal
cancer patients [111-114]. With the advent of formal sci-
ence-based medicine in the early 1900s, this approach
slipped into oblivion.
Animal studies performed in the 1960s demonstrated the
effectiveness of pancreatin therapy for tumors [115,116].
It was also demonstrated that orally ingested pancreatic
enzymes pass intact into the intestine, and are re-adsorbed
into the circulation during the enteropancreatic recycling
process [117,118]. In the 1960s, an alternative physician
in Texas developed a pancreatin-based cancer therapy
[119] and demonstrated cases of pancreatic cancer
patients who survived in excess of 5 years. This was fol-
lowed up in the late 1990s by a pilot prospective case
study with patients having inoperable stage II-IV pancre-
atic adenocarcinoma [120]. The results suggested a signif-
icantly increased survival for patients who received large
doses of pancreatic enzymes, vitamins and minerals fol-
lowed by the detoxification of the intestines. Many medi-
cal practitioners in the past included intestinal cleansing
as part of their procedures because they recognized the
importance of the gut function in health and disease [121-
123].
The resident bacterial flora in the digestive tract plays an
important role in metabolic activities, nutrient adsorp-
tion, immune function, trophic effects on the intestinal
epithelia, and protection against alien microbes [124]. A
substantial portion of these bacterial populations remains
to be described. Diet has a significant effect on the human
intestinal flora [125,126], and the promoting effects of
the large bowel contents in colonic carcinogenesis are
documented both in animal models and man [127]. The
activity of colonic bacteria in the release of essential phe-
nolic polysaccharides from plant cell walls has been dis-
cussed. Opportunistic bacterial and parasitic infections
also occur in cancer [128-131] that amplify the downward
spiral of diminishing nutrient processing capacity of the
gut. It is therefore critical to cleanse the digestive and
excretory system in cancer patients.
Again, if we research the medical practices of the 19th and
early 20th centuries, we find that oral sulfur was widely
used to "clean out the system" [31]. Sulfur is safe to con-
sume [132] and has a wide spectrum of antibacterial and
antiparasitic effects [133]. It is also a potent scavenging
agent for toxic heavy metals such as mercury, cobalt or sil-
ver that have been reported to concentrate in malignant
tissue [97]. Oral sulfur was listed in the Pharmacopoiea
[133], but in the second half of the 20th century its medi-
cal use was abandoned. Another sanitizing agent both for
the gut and the urinary system is apple cider vinegar
(ACV). Such use of ACV has a historical record dating back
over 3,000 years [134]. In addition, ACV has been used for
the treatment of a number of specific conditions [134],
which suggests that it has a beneficial systemic effect,
much of it remains to be re-discovered by methods of
modern medical science.Journal of Carcinogenesis 2003, 2 http://www.carcinogenesis.com/content/2/1/9
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Subtle energetic properties of nutrients
A subtle energetic aspect of nutrients is a concept that is
largely missing from modern nutritional sciences. We are
all familiar with the different feeling experienced when
consuming a freshly picked fruit versus a stale one that has
been sitting for weeks on the shelves of a food distribution
outlet. Some Asian cultures attribute such subtle energetic
characters to nutrients, e.g., the yin and yang that is related
to chi, the life energy believed to animate every living
thing. With our food we consume this energy, which
enhances its nutritional value. Freshness of food is
emphasized in these cultures, as the life energy is gradu-
ally lost after harvest. The consumption of raw, fresh
foods in Japan has already been correlated with a low inci-
dence of the major forms of cancer.
This concept was impossible to subject to modern scien-
tific analysis until Wilhelm Reich proved experimentally
the existence of a life energy field that is not electromag-
netic in nature, but can produce thermal and electric
effects in a well reproducible and quantifiable manner
[135]. A recent academic study has confirmed Reich's
basic findings [136,137]. The incorporation of his meth-
odologies into our working knowledge base could add an
exciting new dimension to nutritional science, as we may
finally be able to quantify "what health is" and defini-
tively establish what kind of nutrient intake is required for
long term health.
Reich also made fundamental contributions to under-
standing the emotional aspects of the disease process and
in particular cancer that he determined to be a manifesta-
tion of subtle energetic processes in the body [138]. We
are now aware that emotional stress down-regulates the
immune system and makes people more prone to cancer
[139-142]. Reich's analysis of the subtle energetic proc-
esses in cancer patients and their relationship to those
emotional blocks makes his research perhaps the most
original and intriguing area of study in the history of 20th
century medical science.
Although Reich was occasionally skeptical about a possi-
ble unification of his subtle energy-based approach to
cancer versus our mechanistic, physico-chemical
approach, there seems to be no conflict between these
methodologies, and instead I suggest that they merely rep-
resent different observational levels of the same reality.
The unification of a subtle energetic description of disease
processes with our current mechanistic, physico-chemical
approach is both inevitable and necessary to solving the
mysteries of degenerative diseases such as cancer, which
claim so many lives today.
Overcoming tumor adaptation
Acquired drug resistance is a common problem with met-
astatic cancers, contributing to the deaths of more than
450,000 patients annually in the US [143]. A tumor may
respond initially to therapy but recur later with acquired
drug resistance, or exhibit an intrinsic resistance from the
outset. Multidrug-resistance (MDR) manifests through an
ATP-dependent drug efflux pump, the P-170 glycoprotein
or MDR pump [144]. Quinine has been found to reverse
MDR in a variety of tumor cell lines and has been safely
used in combination with chemotherapy with leukemias,
myelomas and lymphomas [145-147]. Very little infor-
mation is available on direct cytotoxic effects of quinine
[148].
Quinine has a history in medicine besides its use as an
anti-malarial. Quinine was used to treat inflammations
and fevers [149] and was prescribed as a body tonic to
strengthen the system [149,150]. The beverage Tonic
Water has preserved in its name the long-forgotten medic-
inal origins of quinine. However, the concentration of
quinine in Tonic Water today is too low for any beneficial
systemic effect. Therefore, the use of quinine in cancer
may be warranted both for its anti-inflammatory proper-
ties as well as its inhibitory effect on tumor adaptation to
therapies.
Discussion
This review has considered several critical nutrient defi-
ciencies that may contribute to the manifestation of a
number of cancers, as well as nutrients that have been
found deficient in cancer cells. It is also observed that tra-
ditional nutritional and medicinal agents used in the past
provided a rich supply of these critical nutrients and
assisted in the restoration of digestive and excretory func-
tions. Again, blackstrap molasses is a source of plant phe-
nolic compounds, the majority of the vitamin B complex,
critical minerals such as iron, zinc, selenium, magnesium
and potassium, as well as essential unsaturated lipids.
Rose oil is another historically proven source of essential
lipids. Our current understanding on the vital role of
folate and vitamin B12 in maintaining DNA integrity and
function should prompt us to reevaluate dietary require-
ments for these essential vitamins. Iodine deficiency,
which has been demonstrated in cancer, was also shown
to impair the immune system and increase the incidence
of several cancers. The disinfecting effects of oral sulfur
and apple cider vinegar in the gut and the urinary system
help restore digestive and excretory functions, a corner-
stone of early medical practice.
A large number of studies demonstrate the inadequacy of
Western dietary habits for supplying adequate amounts of
critical nutrients and also demonstrate the fundamentalJournal of Carcinogenesis 2003, 2 http://www.carcinogenesis.com/content/2/1/9
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role of nutrition in disease prevention and control.
Hippocrates, the father of modern medicine stated, "Your
food shall be your medicine and your medicine shall be
your food." Currently, both in the public and the scientific
community are lacking in their attention to the effects of
multiple nutritional deficiencies on the human organism.
It seems reasonable to conclude that a number of coinci-
dental critical nutritional deficiencies can lead to and co-
exist in the state of cancer. Disregulation of numerous reg-
ulatory and metabolic pathways may occur at multiple
levels, eventually leading to the disintegration of meta-
bolic and regulatory networks in terminal cancer. This
suggests that cancer is a systemic disease, and that a tumor
is likely a late-stage effect rather than the cause of the dis-
ease itself. It also explains why cancer typically recurs after
the eradication of individual tumors. Therefore, focusing
on the cancer cell cannot lead us to understanding the
fundamentals of the disease. Here, the results speak for
themselves.
It appears unrealistic that we can successfully intervene
into this vast out-of-balance network of physiological
processes with single active agent therapies and restore
balance and health. The time has arrived to abandon one-
dimensional thinking and consider the human organism
more like a matrix or interconnected system, instead. The
large body of available data on metabolic and regulatory
processes coupled with methods of information technol-
ogy should allow us to establish correlations between
apparently distant molecular, cellular and physiological
events. This would bring a true paradigm shift in our
approach to understanding and treating diseases.
The old-time medicinal use of blackstrap molasses, apple
cider vinegar, oral sulfur and molecular iodine, rose oil
and quinine testifies to a remarkable understanding of
human physiology by our ancestors. Such nutritional
approach allows a unifying perception of cancer that
could recast it as a single disease. This would also suggest
that all cancers may arise out of a common cellular/phys-
iological event and, in fact, new evidence points into this
direction.
Cancer stem cells for leukemias [151], brain cancer [152]
and breast cancer [153] have been described lending sup-
port to the 40 years old idea that all cancers may originate
from a common progenitor. Thus, evidence is accumulat-
ing in support of the view that cancer may actually be a
single disease and, as such could be treated by a single
therapy.
Our working hypothesis was that by re-supplying critical
nutrients to cancer patients in an oral nutritional supple-
ment cocktail and simultaneously cleansing the digestive
and excretory systems by using the described methods of
past centuries of medicine, we might cure a wide range of
or perhaps all types cancers. Essential ingredients of the
supplement include blackstrap molasses, apple cider vin-
egar, sulfur, quinine, rose oil, folic acid, vitamin B12 and
molecular iodine [patent pending]. This supplement is
currently being tested in a variety of stage III-IV cancer
patients refractory to current therapies.
In conclusion, this paper presents the case that multiple,
concurrent nutritional deficiencies may play a fundamen-
tal role in tumorigenesis and suggests that the disease
process could be reversed by re-supplying the required
nutrients in adequate amounts. In addition, a new
approach to cancer is advocated that would unify our tra-
ditional mechanistic, physico-chemical methodologies
with subtle energy-based concepts, under the umbrella of
contemporary rigorous scientific testing methods.
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